The Cigna Group (NYSE: CI), a healthcare company focused on medical insurance and related services, Thursday reported a sharp increase in revenues for
Cigna Group (CI) reports double-digit revenue growth for Q1; guides FY24
Categories
Health Care
Infographic: A snapshot of Moderna’s (MRNA) Q1 2024 earnings results
Moderna, Inc. (NASDAQ: MRNA) reported a net loss for the first quarter of 2024 when the biotechnology company's revenues declined sharply. Q1
Key takeaways from Pfizer’s (PFE) Q1 2024 earnings report
Shares of Pfizer Inc. (NYSE: PFE) gained over 5% on Wednesday following the company’s announcement of its first quarter 2024 earnings results.
CVS Health Q1 adj. earnings drop despite revenue growth; guides FY24
Healthcare conglomerate CVS Health Corporation (NYSE: CVS) announced first-quarter 2024 results, reporting higher revenues and a decrease in adjusted earnings. March-quarter adjusted
Pfizer (PFE) Q1 2024 Earnings: Key financials and quarterly highlights
Pfizer Inc. (NYSE: PFE) reported first quarter 2024 earnings results today. Revenues decreased 20% year-over-year to $14.8 billion. Reported net income declined
Key highlights from Eli Lilly’s (LLY) Q1 2024 earnings results
Eli Lilly and Company (NYSE: LLY) reported first quarter 2024 earnings results today. Worldwide revenue was $8.77 billion, up 26% from the
Highlights of AbbVie’s Q1 2024 financial results
Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and a modest
Key highlights from Bristol Myers Squibb’s (BMY) Q1 2024 earnings results
Bristol Myers Squibb (NYSE: BMY) reported first quarter 2024 earnings results today. Total revenues increased 5% year-over-year to $11.9 billion. When adjusted
MRK Earnings: Merck Q1 2024 profit jumps on 9% revenue growth
Pharmaceutical company Merck & Co. Inc. (NYSE: MRK) reported a sharp increase in adjusted earnings for the first quarter of 2024, aided
BIIB Earnings: Biogen Q1 2024 adj. earnings rise despite lower revenues
Biotechnology firm Biogen Inc. (NASDAQ: BIIB) Wednesday reported an increase in adjusted profit for the first quarter of 2024, despite a decline
Earnings: Trxade Health (MEDS) reports lower revenues for fiscal 2023
Trxade Health, Inc. (NASDAQ: MEDS), a leading health service IT company, reported a decline in revenues for fiscal 2023. The company’s full-year
ISRG Earnings: Intuitive Surgical reports higher Q1 revenue and profit
Medical device company Intuitive Surgical, Inc. (NASDAQ: ISRG) announced operating results for the first quarter of 2024, reporting higher revenues and adjusted
Key takeaways from Johnson & Johnson’s (JNJ) Q1 2024 earnings report
Over the years, Johnson & Johnson (NYSE: JNJ) has constantly ramped up its portfolio and pipeline. After spinning off the consumer health
Key highlights from Abbott Laboratories (ABT) Q1 2024 earnings results
Abbott Laboratories (NYSE: ABT) reported its first quarter 2024 earnings results today. Total sales increased 2.2% year-over-year to $10 billion. Organic sales growth
Infographic: How UnitedHealth Group (UNH) performed in Q1 2024
UnitedHealth Group (NYSE: UNH) reported its first quarter 2024 earnings results today. Revenues increased 9% year-over-year to $99.8 billion. Net loss attributable
JNJ Earnings: Key quarterly highlights from Johnson & Johnson’s Q1 2024 financial results
Johnson & Johnson (NYSE: JNJ) reported first quarter 2024 earnings results today. Reported sales increased 2.3% year-over-year to $21.4 billion. The company
Earnings Preview: UnitedHealth (UNH) looks poised to deliver another strong quarter
After delivering a solid performance last year, UnitedHealth Group (NYSE: UNH) will be reporting first-quarter financial data next week. The healthcare conglomerate’s
PACS Group gears up for $400 million IPO. Here’s all you need to know
After a slow start to the year, the IPO market is witnessing a rush of tech and healthcare companies seeking to go
ANGO Earnings: Highlights of AngioDynamics’ Q3 2024 results
AngioDynamics Inc. (NASDAQ: ANGO) has reported a wider net loss for the third quarter of 2024 when the medical device maker's revenue
Femasys is committed to providing women with revolutionary healthcare products: CEO
Femasys Inc. (NASDAQ: FEMY) is a healthcare company that develops women's reproductive health solutions using state-of-the-art technology. The company’s portfolio includes minimally
WBA Earnings: Walgreens Boots Alliance Q2 profit and sales beat estimates
Walgreens Boots Alliance, Inc. (NASDAQ: WBA) on Thursday reported stronger-than-expected earnings and revenues for the second quarter of 2024. Net profit, on